0
0
69 words
0
Comments
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation chemotherapy combined with temozolomide is the standard line of treatment, GBM cells surviving radiotherapy contribute to tumor progression and recurrence…
You are the first to view
https://www.sciencedaily.com/releases/2023/01/230118092036.htm
Create an account or login to join the discussion